The manager of the drugs control department said that importation of Oral-lyn can be done via the issuance of a purchase order from the Imperial College London Diabetes Centre to a drug store or pharmacy licensed by the Ministry of Health of the United Arab Emirates.
Anna Gluskin, president and CEO of Generex, said: “We are pleased with the progress made by our Leosons General Trading Company. This step is significant in that it allows the company to introduce Generex Oral-lyn into the Middle East via an established organization with a strong diabetes treatment program. We anticipate that this model will serve the purpose of demonstrating the product’s safety and efficacy to other health agencies within the Middle East.”